- Home
- BROS vs QGEN Comparison
BROS vs QGEN Comparison
Compare BROS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BROS
- QGEN
- Stock Information
- Founded
- BROS 1992
- QGEN 1986
- Country
- BROS United States
- QGEN Netherlands
- Employees
- BROS N/A
- QGEN N/A
- Industry
- BROS Restaurants
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BROS Consumer Discretionary
- QGEN Health Care
- Exchange
- BROS Nasdaq
- QGEN Nasdaq
- Market Cap
- BROS 9.1B
- QGEN 10.3B
- IPO Year
- BROS 2021
- QGEN 1996
- Fundamental
- Price
- BROS $64.59
- QGEN $45.29
- Analyst Decision
- BROS Strong Buy
- QGEN Buy
- Analyst Count
- BROS 18
- QGEN 8
- Target Price
- BROS $81.00
- QGEN $51.01
- AVG Volume (30 Days)
- BROS 3.3M
- QGEN 1.4M
- Earning Date
- BROS 11-05-2025
- QGEN 11-05-2025
- Dividend Yield
- BROS N/A
- QGEN 3.33%
- EPS Growth
- BROS 75.89
- QGEN 405.09
- EPS
- BROS 0.48
- QGEN 1.69
- Revenue
- BROS $1,451,963,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- BROS $27.79
- QGEN $7.22
- Revenue Next Year
- BROS $24.80
- QGEN $5.66
- P/E Ratio
- BROS $134.69
- QGEN $27.20
- Revenue Growth
- BROS 29.80
- QGEN 5.15
- 52 Week Low
- BROS $30.49
- QGEN $37.63
- 52 Week High
- BROS $86.88
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- BROS 45.42
- QGEN 33.28
- Support Level
- BROS $63.67
- QGEN $46.27
- Resistance Level
- BROS $66.77
- QGEN $47.93
- Average True Range (ATR)
- BROS 3.04
- QGEN 0.76
- MACD
- BROS -0.77
- QGEN -0.22
- Stochastic Oscillator
- BROS 8.38
- QGEN 0.00
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).